Trinity Biotech plc

Equities

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-19 pm EDT			5-day change	1st Jan Change
1.805 ^USD	-3.97%		-2.94%	-15.83%

Apr. 18	European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	MT
Apr. 17	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT

Trinity Biotech plc announced that it has received $81.25 million in funding from Perceptive Advisors LLC

January 26, 2022

Trinity Biotech plc announced that it has received $81,250,000 in funding on January 27, 2022. The company has received senior secured term loan credit facility in the transaction. The transaction included participation from new investor Perceptive Advisors LLC.

Latest news about Trinity Biotech plc

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	Apr. 18	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	Apr. 12	MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Apr. 11	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05	MT
Transcript : Trinity Biotech plc, Q4 2023 Earnings Call, Apr 04, 2024	Apr. 04
Trinity Biotech plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 04	CI
Trinity Biotech plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	Mar. 27	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	Mar. 26	MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	Mar. 20	MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	Mar. 13	MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading	Mar. 11	MT
Trinity Biotech Says it Regained Compliance With Nasdaq's Minimum Bid Price Rule	Mar. 08	MT
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	Mar. 01	MT
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading	Feb. 26	MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	Feb. 22	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	Feb. 15	MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Wednesday Trading	Feb. 14	MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	Feb. 13	MT
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading	Feb. 12	MT
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading	Feb. 09	MT
European Equities Traded in the US as American Depositary Receipts Slightly Lower in Wednesday Trading	Feb. 07	MT
European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading	Feb. 06	MT

Chart Trinity Biotech plc

Duration

Period

More charts

Company Profile

Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
TRINITY BIOTECH PLC	-15.83%	17.75M
BIOMÉRIEUX	-1.04%	12.47B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-17.29%	6.99B
DIASORIN S.P.A.	-2.21%	5.1B
LANTHEUS HOLDINGS, INC.	+2.92%	4.27B
AUTOBIO DIAGNOSTICS CO., LTD.	-4.79%	4.27B
10X GENOMICS, INC.	-50.07%	3.45B
ANDON HEALTH CO., LTD.	+7.65%	2.61B
VITROLIFE AB	-15.92%	2.08B
MYRIAD GENETICS, INC.	-3.34%	1.67B

Diagnostic & Testing Substances